| Literature DB >> 29648503 |
Victor Pena Ribeiro1, Caroline Arruda1, Mohamed Abd El-Salam1, Jairo Kenupp Bastos1.
Abstract
CONTEXT: Inflammatory disorders are common in modern life, and medicinal plants provide an interesting source for new compounds bearing anti-inflammatory properties. In this regard, Brazilian medicinal plants are considered to be a promising supply of such compounds due to their great biodiversity.Entities:
Keywords: COX; NF-κB; PGE2; ROS
Mesh:
Substances:
Year: 2018 PMID: 29648503 PMCID: PMC6130656 DOI: 10.1080/13880209.2018.1454480
Source DB: PubMed Journal: Pharm Biol ISSN: 1388-0209 Impact factor: 3.503
Figure 1.Chemical structures of some selected secondary metabolites with anti-inflammatory activity.
Figure 2.Anti-inflammatory targets of compounds in the inflammatory response.
Anti-inflammatory mechanisms of action of compounds from Brazilian medicinal plants.
| Plant | Bioactive molecules | Mechanisms involved in the anti-inflammatory effects | References |
|---|---|---|---|
| Quercitrin, isoquercitrin, 3- | Reduction of IFN-γ and IL-4 ratio | Cosentino et al. ( | |
| 5′-Methoxy nobiletin, 1,2-benzopyrone, eupalestin | Reduction of nitric oxide metabolites concentrations (NOx) inhibition NF-κB | Mello et al. ( | |
| Phenolic compounds, anthocyanins, flavonoids, alkaloids, saponins, luteolin, pigenin, orientin, quercetin, vitexin | Non-elucidated mechanism | Formagio et al. ( | |
| Afrormosin | Inhibition of ROS generation | Lopes et al. ( | |
| N.R. | Reduction of inducible nitric oxide (iNO) | Olajide et al. ( | |
| Flavonoid, saponins, catequins, phenols, steroids, tannins, terpenoids | Non-elucidated mechanism | Santos et al. ( | |
| N.R. | Preventing lipid peroxidation through reducing thiobarbituric acid reactive substances (TBARS). | Desmarchelier et al. ( | |
| Populnoic acid, campesterol, stigmasterol, sitosterol, epitaraxerol, amirine, lupenone, lupeol, lupeol acetate, friedalanol, friedelin | Non-elucidated mechanism | Andrade et al. ( | |
| Caffeic acid, | Inhibition of lipid peroxidation and ROS release- COX | Cestari et al. ( | |
| Ursolic acid, oleanoic acid, micromeric acids lamiide | Prevention of lipid peroxidation through reducing thiobarbituric acid reactive substances (TBARS) | Delaporte et al. ( | |
| Flavonoids, triterpenes, steroids, tannins saponins, catechin, phenolic compounds | Inhibition of protein kinase C and/or larginine-NO pathways | Orlandia et al. ( | |
| Polyphenolic compounds | Highest free radical scavenging activities | Vargas et al. ( | |
| Polysaccharides | Negative modulation of histamine, serotonin, bradykinin, PGE2 and NO released | Pereira et al. ( | |
| Myricitrin and myricetin (320 μg/mL 6.25–100 μM, respectively) | Inhibition of NO production | Ferreira et al. ( | |
| 6α-acetoxygedunin, 7-deacetoxy-7-oxogedunin, 6a-acetoxyepoxyazadiradione, methyl angolensate, andirobin and gedunin | Inhibiting IL-1 and TNF-α | Penido, Conte, Chagas, et al. ( | |
| Fatty acids, phenolic compounds, carotenoids, tocopherols, fitosterols | Reduction of the concentration of IL-6, IL-5 and TNF-α | Torres et al. ( | |
| Vicenin-2, spinosin, sovitexin, swerticin, isoswerticin, cucurbitacins | Inhibition of iNOS- COX | Recio et al. ( | |
| Caffeoylquinicn acids, hyperoside, quercetrin, isoquercetrin, luteolin, apigenin, chrysoerio, eremantholide, goyazensolide, isorhamnetin | Inhibition of COX production | Chagas-Paula et al. ( | |
| Milonine | Reduction levels of IL-1 and TNF-α | Silva et al. ( | |
| Limonene and β-myrcene | Inhibition of NO production | Souza et al. ( | |
| β-Caryophyllene and kaurenoic acid | Inhibition of NO production | Veiga Junior et al. ( | |
| (−)- | Reduction of PGE2 | Fernandes et al. ( | |
| N.R. | Free radicals scavenging activity | Nardi et al. ( | |
| N.R. | Inhibition of PGE2 | Alexandre-Moreira et al. ( | |
| N.R. | SOD scavenging activities | Chan et al. ( | |
| Ellagic acid, gallic acid and rutin | Free radical scavenging activity | Schumacher et al. ( | |
| Plumericin | Inhibition of NF-κB | Fakhrudin et al. ( | |
| N.R. | Reduction of inflammatory mediators (nitric oxide, prostaglandin E2, IL-6 and TNF-α) | Raymundo et al. ( | |
| Saponins, alkaloids, phenolic | Non-elucidated mechanism | Ferreira-Rodrigues et al. ( | |
| Coumarins, flavonoids, saponins, tannins | Non-elucidated mechanism | Leal et al. ( | |
| Kalanchosine, dimalate, kalanchosine, malic acid | Non-elucidated mechanism | Mourão et al. ( | |
| Costunolide, parthenolide | Non-elucidated mechanism | Kassuya et al. ( | |
| Lupeol, sitosterol, ursolic acid and flavonoids. | Inhibition of IL-6 and TNF-α | Magalhães et al. ( | |
| Ursolic acid, oleanoic acid | Non-elucidated mechanism | Vasconcelos et al. ( | |
| Coumarin | Non-elucidated mechanism | Fierro et al. ( | |
| Urundeuvines I, urundeuvines II, urundeuvines III, taninns | Non-elucidated mechanism | Souza et al. ( | |
| Galgravin, veraguensin | Non-elucidated mechanism | Da Silva Filho et al. ( | |
| Flavanones, flavones, free flavonoids, flavonols, coumarins, steroids, phenols cyanogenic heterosides, cardioactive glycosides, leucoanthocyanidins, saponins, tannins and xanthones | Non-elucidated mechanism | Pereira et al. ( | |
| Coronaridine, tabersonine, olivacine, coronaridine-hydroxyindolenine, catharinensine, decarbomethoxyvoacamine, tabernamine, vanillic acid, syringic acid, gentisic acid and salicylic acid | Non-elucidated mechanism | Rates et al. ( | |
| S-Propyl propanethiosulfinate and S-benzyl phenylmethanethiosulfinate | Inhibition of as IL-1, IL-2, INF-γ, TNF-α and IL-6 | Lopes-Martins et al. ( | |
| Steroids, triterpenes, flavonoids, cinnamic derivatives and noradrenaline | Non-elucidated mechanism | D’Angelo et al. ( | |
| Flavonoids, alkaloids, terpenoids, phenolic compounds and iridoid glycosides | Inhibition of PGE2 | Adom et al. ( | |
| Gallic acid, myricitrin, guaijaverin, quercitrin, corosolic acid, maslinic acid, oleanolic acid and ursolic acid | Non-elucidated mechanism | Azevedo et al. ( | |
| Inhibition of NO production | Souza et al. ( | ||
| Spathulenol, sesquiterpenes | ROS scavenging activity | Nascimento et al. ( | |
| Lupeol, botulin and 6a, 7b-dihydroxy-vouacapan-17b-oic | Inhibition of PGE2 | Galceran et al. ( | |
| Rutin and quercetin as major compounds, and chlorogenic acid. | ROSD and NO scavenging activities | Bahiense et al. ( | |
| Gallic acid | Inhibition of TNF-α | Santos et al. ( | |
| Betulinic acid | Reduction of the levels of COX-2, NO, TNF-α and IL1-β in inflamed tissues | Tsai et al. ( | |
| NF-κB-COX-inhibition of TNF-α | De Aquino et al. ( | ||
| Ipolamiide, verbacoside | Non-elucidated mechanism | Penido, Conte, Chagas, et al. ( | |
| 2-Formyl-5-(4′-methoxybenzoyloxy)-3-methyl-2-cyclopentene-1-acetaldehyde | Non-elucidated mechanism | Koyama et al. ( | |
| Uncarine F, mitraphyllene, speciophylline, pteropodine and isopteropodine | NF-κB-inhibition of IL-1, IL-17 and TNF-α | Allen-Hall et al. ( | |
| Bisabolol, α-cadinol, elemicin, β-bisabolene, guaiene, cubebene and Estragole | Non-elucidated mechanism | Santos et al. ( | |
| Titonine | Non-elucidated mechanism | Carvalho, Ferreira, et al. ( | |
| Cucurbitacins, dihydrocurcubitacin B, curcubitacins analogues | Inhibition of NO release-COX | Peters et al. ( | |
| Phenolic compounds, flavonoids, tannins and glycosides | Non-elucidated mechanism | Olabissi et al. ( | |
| Sesamin, methylpluviatolide, dimethylmatairesinol, piperitol-4′- | Non-elucidated mechanism | Lima et al. ( | |
| Zeyherin A, zeyherin b, oleanoic acid and ursolic acid | Non-elucidated mechanism | Guenka et al. ( |
N.R.: not reported.